Parabilis Medicines Inc PBLS
$40.42 $0.33 (0.81%) 1D
Last Updated: Sep 04, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
P
Is Parabilis Medicines Inc Stock Halal?
Shariah Compliance Analysis of PBLS Stock
United States Health Care Mid Cap No. As of September 2026, Parabilis Medicines Inc (PBLS) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Parabilis Medicines Inc does not pass Musaffa's business and financial screening criteria.
Parabilis Medicines Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Cambridge, Massachusetts and currently employs 145 full-time employees. The company went IPO on 2026-06-10. Parabilis Medicines, Inc., formerly FOG Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The company is built to develop transformative medicines addressing undruggable protein targets driving human disease. The company leverages a proprietary platform to a novel therapeutic modality, Helicons, which are stabilized helical peptides engineered to bind and precisely modulate proteins that reach conventional medicine. Its lead product candidate, zolucatetide, is the first and only investigational therapy that inhibits the b-catenin: TCF interaction, the critical downstream node of the Wnt/b-catenin pathway. Its preclinical pipeline provides Helicon approach and includes programs targeting two key drivers of prostate cancer, the ETS-related gene and the androgen receptor (AR) in its active state (ARON). Helicon discovery platform integrates advanced AI and physics-based computational modeling with peptide synthesis and experimental screening to discover and develop drug candidates.
PBLS Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Parabilis Medicines Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Parabilis Medicines Inc (PBLS) Chart
Financial Metrics & Statements of Parabilis Medicines Inc (PBLS)
FAQ's for Parabilis Medicines Inc (PBLS)
- As of September 2026, Parabilis Medicines Inc PBLS is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Parabilis Medicines Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Parabilis Medicines Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Parabilis Medicines Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Parabilis Medicines Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Parabilis Medicines Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Parabilis Medicines Inc (PBLS)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
